Vets Plus, Inc.

9 patents currently held · Updated Nov 14, 2026

Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Ending by 2030

Feb 2036

Next term end

When these terms end

5 yrs10 yrs20 yrs

Held patents by the year their term ends

20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.

1 fee due Mar 10, 2027
The maintenance fee for Oral Delivery Compositions for Treating Dermatitis Disorders in Mammals (US 10,406,232) comes due Mar 10, 2027. Unpaid by Sep 10, 2027, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

1 term has ended since Aug 16, 2026

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.

Showing 1 to 9 of 9

Patent	Title	Status	Expires	Confidence
US 9,662,356	Propolis-Metal Nanoparticle Composition and Methods of Use In force Term ends Feb 1, 2036 · High confidence	In force	Term ends Feb 1, 2036	High confidence
US 10,406,232	Oral Delivery Compositions for Treating Dermatitis Disorders in Mammals In force Term ends Mar 9, 2036 · High confidence	In force	Term ends Mar 9, 2036	High confidence
US 9,968,548	Dental Hard Chew Supplements Containing Antimicrobial Actives In force Term ends Mar 29, 2036 · High confidence	In force	Term ends Mar 29, 2036	High confidence
US 10,905,748	Ovotransferrin Treatment for the Reproductive Tract In force Term ends Aug 3, 2038 · High confidence	In force	Term ends Aug 3, 2038	High confidence
US 12,083,167	Ovotransferrin Treatment for the Reproductive Tract In force Term ends Aug 3, 2038 · High confidence	In force	Term ends Aug 3, 2038	High confidence
US 12,076,374	Anti-Microbial and Anti-Inflammatory Compositions and Methods for Treating Enteric Diseases in Animals In force Term ends Jan 3, 2040 · High confidence	In force	Term ends Jan 3, 2040	High confidence
US 12,390,513	Compositions and methods for treating pancreatic enzyme deficiencies in mammals In force Term ends Apr 4, 2040 · From the USPTO record	In force	Term ends Apr 4, 2040	From the USPTO record
US 11,547,745	Compositions and Methods for Treating Pancreatic Enzyme Deficiencies in Mammals In force Term ends Apr 17, 2040 · High confidence	In force	Term ends Apr 17, 2040	High confidence
US 11,357,802	Oral Delivery Compositions for Improved Gut Barrier Protection and Immunity in Mammals In force Term ends Oct 27, 2040 · High confidence	In force	Term ends Oct 27, 2040	High confidence

Also on record, not counted in the 9: 2 lapsed for an unpaid fee · 3 ended at full term. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built

Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Export every term end as CSV · Pro

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

1 pending · 2 no status recorded

List them